Navigation Links
ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
Date:12/5/2007

r is the most frequently diagnosed cancer in American women and the second leading cause of cancer-related deaths in women after lung cancer. Over 214,000 new cases of breast cancer and over 41,000 deaths from breast cancer are expected in the U.S. in 2006. Despite advances made in treatment options that have led to a significant increase in survival and quality of life, metastatic disease is still incurable. Five-year survival rates decrease with advancing disease stage: from 98% in localized disease to 80% with regional spreading to only 26% with metastatic disease.

About ANX-510, or CoFactor

CoFactor is a folate-based biomodulator drug designed to replace leucovorin as the preferred method to enhance the activity and reduce associated toxicity of the widely used cancer chemotherapeutic agent 5-FU. Compared to leucovorin, CoFactor creates more stable binding of the active form of 5-FU to the target enzyme, thymidylate synthase (TS). CoFactor bypasses the metabolic pathway required by leucovorin to deliver the active form of folate, potentially allowing 5-FU to work more effectively.

In October 2007, ADVENTRX announced the results from its Phase 2b clinical trial of CoFactor for the treatment of metastatic colorectal cancer. The CoFactor/5-FU arm did not demonstrate statistically significant improved safety in the trial's primary endpoint, a reduction in the proportion of patients reporting at least one hematological or gastrointestinal adverse event of grade 3 or greater. Further analysis of the Phase 2b study, in which 5-FU was administered by infusion, has uncovered no significant differences between the study arms with regard to either efficacy or safety. In November 2007, ADVENTRX announced that it would discontinue enrolling patients in its Phase 3 clinical trial of CoFactor for the first-line treatment of metastatic colorectal cancer.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a biopharmaceutical research an
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
3. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... -- Today, humanity takes a massive step toward reaching our ... 1-800 CONTACTS announces their new Apple Watch app which allows ... Two taps. New contacts. From your watch. We ... features LensGauge which helps keep track of how long your ... "Since our inception, we,ve been dedicated to providing ...
(Date:4/24/2015)... 2015  A new study shows an "alarming rise" over ... to slow the progression of multiple sclerosis or reduce the ... at Oregon Health & Science University (OHSU) and Oregon State ... of MS drugs in the marketplace over the past 20 ... for patients who use those drugs. Researchers found the costs ...
(Date:4/24/2015)... April 24, 2015  Span-America Medical Systems, Inc. ... its fiscal 2015 second quarter results on Thursday, April ... The company will conduct a conference call ... to review the company,s financial and operating results for ... broadcast of the conference call will be available ...
Breaking Medicine Technology:Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch 2Researchers find alarming rise in cost of MS drugs over past two decades 2Researchers find alarming rise in cost of MS drugs over past two decades 3Researchers find alarming rise in cost of MS drugs over past two decades 4
(Date:4/24/2015)... 24, 2015 With years of experience ... is now proud to be partnered with a veterinary ... animals a year. This partnership has brought new payment ... , After providing an in-house payment plan for ... Hospital (VMTH) wanted to increase financing options available to ...
(Date:4/24/2015)... 2015 IntelliSoft Group, LLC, a ... contract management software, featured IntelliCred Version 14.2 during ... Annual Educational Conference (IAMSS) on April 23-24 ... Brook, Illinois. , Notable improvements available in IntelliSoft’s ... , Contract Linking: A new Contract Connection ...
(Date:4/24/2015)... Telematics Berlin is the foremost Automotive ... & 2 suppliers, content providers, associations and government bodies. ... value chain, see them converge in Berlin. This year’s ... from those companies currently at the forefront of Europe’s ... on customer centric products, ParkTAG are one of the ...
(Date:4/24/2015)... Yisrayl Hawkins, Pastor and Overseer at The House of ... forces are used worldwide, and how they would not be ... says that the nations have been trained to build up ... to the confusion and distrust. , “The nations believe ... forced compliance, unjust rules and laws, and the rape of ...
(Date:4/24/2015)... 2015 Recent research by the CareerBuilder ... therapists and their assistants are among the top 10 ... by the year 2023. , Physical therapists are ... growth and greatest potential for expansion in the future. ... that while physical therapists can offer great relief to ...
Breaking Medicine News(10 mins):Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2Health News:IntelliSoft Group Version 14.2 of IntelliCred featured at the Illinois Association of Medical Staff Services Annual Educational Conference 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 3Health News:Armed Forces Would Not Be Necessary if Biblical Laws Were Followed, Says Yisrayl Hawkins in New Article 2Health News:Huntsville Medical Doctor Explains Why Physical Therapy May Not Treat Muscle Numbness Adequately 2
... Surayud Chulanont, has defended his government's move to allow the ... of US worries over intellectual property rights in the kingdom. ... we can explain our action to other countries as well ... This Tuesday, Health Minister Mongkol Na Songkhla will be traveling ...
... old man that visits a doc, there is a woman; much like ... for success. ,Some Older men need to be goaded ... has revealed The woman could be a wife, daughter or even a ... of men above 50 years visit a doctor only after being coaxed ...
... is not funny. Infact their love for the spirits has ... by the fallout of the binge drinking culture on the ... trend evident among all age groups, class, boundaries and cultural ... Australia in the next 20 years. Many Australians will be ...
... over a long period of time may decrease brain volume, ... Academy of Neurology's 59th Annual Meeting in Boston, April ... MRI scans of 1,839 people from the Framingham Offspring study, ... drinkers, low drinkers (one to seven drinks per week), moderate ...
... cells that can repair the most severe damage to the ... lie around and do nothing, but when neighboring cells ... A report on the discovery will appear online next week ... cells act like the Army Reserves of our nose, explains ...
... of Rhode Island have demonstrated a new way to target ... protein that acts like a nanosyringe to deliver tags or ... of the National Academy of Sciences. ... (Low) Insertion Peptide) can be injected into the abdomen of ...
Cached Medicine News:Health News:Thailand Unfazed As US Worries Over Copyright Violations 2Health News:Drinking Heavy Amounts of Alcohol Shrinks Your Brain 2Health News:When Smell Cells Fail They Call In Stem Cell Reserves 2Health News:Novel Technology to Locate and Treat Tumors 2
... Sepramesh Biosurgical Composite is designed for ... of a PPM mesh that has two ... mesh is coated with a layer of ... Biosurgery's Seprafilm® Adhesion Barrier). This coated side ...
... As Bard, The Hernia Repair Company, ... you may desire limited fibrous tissue in-growth ... as compared to polypropylene mesh. Like all ... prostheses, Reconix Patch produces a clinically proven, ...
... MYCROMESH® PLUS Biomaterial is the first ... for controlling potential operative contamination of ... contains two antimicrobial preservative agents, silver ... to inhibit bacterial colonization on the ...
... its introduction in 1958, Bard mesh has ... products are compared. Bard mesh was used ... developed the "tension-free" hernia repair many years ... safe and ideal" substance for permanent reinforcement ...
Medicine Products: